From the source
9, 2023 - Isomorphic Labs, a digital biology company redefining drug discovery from first principles with an AI-first approach, today announced the formation of its Scientific Advisory Board (SAB).
The company, established in 2021, was launched from Alphabet’s DeepMind to build on the success of AlphaFold , DeepMind’s work in protein folding that was heralded as the “ Breakthrough of the Year ” by Science and “ Method of the Year ” by Nature in 2021 .
Isomorphic Labs aims to usher in a new era of biomedical breakthroughs to find cures for many of humanity’s most devastating diseases.
The scientific advisors are Nobel Prize laureates Jennifer Doudna, David MacMillan, Paul Nurse and Venki Ramakrishnan.
As the inaugural members of the distinguished Isomorphic Labs Scientific Advisory Board, they will draw on their deep expertise and experience to advise the company and its leadership team on scientific and strategic matters, bioethics and other areas where their perspective is beneficial to the company as it scales and develops its technology.
Jennifer Doudna, PhD Dr.
…
